drugset
drugset / Trial / NCT00654095

Coadministration of Ezetimibe and Atorvastatin in Patients With Primary Hypercholesterolemia (P05456)

NCT00654095 ↗

Phase 3 Completed 146 enrolled Organon and Co
Non-randomizedSingle-groupOpen-labelTreatment

Summary

Evaluate the safety of the long-term (1 year) coadministration of ezetimibe and atorvastatin in participants with hypercholesterolemia who have not reached low density lipoprotein (LDL)-cholesterol target with 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors.

Timeline

Start
2007-12-01
Primary completion
2009-06-01
Completion
2009-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 20 mg —
Subject Ezetimibe Unknown 10 mg —

Indications

hyperlipidemia